CIPO Patents = 4

Forward Citations = 10

Loading Chart...

8 inventors (with patents filed for the assignee):

Jose Mendoza (5 out of 8 patents)

Dennis J Thiele (5 out of 8 patents)

Daniel W Neef (5 out of 5 patents)

4. Jose S Mendoza (0 patent)

5 patents: Sort by Forward Citations

1. 9718784 - Substituted pyrazoles as heat shock transcription factor activators (2017-08-01),

2. 9717709 - Substituted pyrazoles as heat shock transcription factor activators (2017-08-01),

3. 9447058 - Substituted 1,3-thiazoles as heat shock transcription factor 1 activators (2016-09-20),

4. 9315449 - Substituted pyrazoles as heat shock transcription factor activators (2016-04-19),

5. 9156775 - Substituted 1,3-thiazoles as heat shock transcription factor 1 activators (2015-10-13),

Chaperone Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for neurodegenerative diseases. With a strong emphasis on chaperone-mediated protein folding, the company aims to target protein misfolding and aggregation in order to treat conditions such as Alzheimer's and Parkinson's disease. By harnessing the power of chaperone proteins, Chaperone Therapeutics is dedicated to advancing novel treatment options for patients in need.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

5 Patents

#120 in Durham, NC

#1,096 in North Carolina

#50,165 in US

Durham, NC, United States of America

Chaperone Therapeutics, Inc.

Forward Citations = 10

8 inventors:

Jose Mendoza (5 out of 8 patents)

Dennis J Thiele (5 out of 8 patents)

Daniel W Neef (5 out of 5 patents)

4. Jose S Mendoza (0 patent)

Please report any incorrect information to support@idiyas.com

4 patents (CIPO):

Please report any incorrect information to support@idiyas.com